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Abstract
Background: Natural products made from plant sources have been used in a variety of cosmetic applications as a
source of nutrition and as a whitening agent. The flowers of Cassia fistula L, family Fabaceae, have been used as a
traditional medicine for skin diseases and wound healing and have been reported to possess anti-oxidant
properties. The anti-aging effect of C. fistula flower extract on human skin fibroblast was investigated.
Methods: The butanolic extraction of C. fistula flowers was completed and the active compounds were classified.
The cytotoxicity of fibroblasts was evaluated by SRB assay for the purposes of selecting non-toxic doses for further
experiments. The collagen and hyaluronic acid (HA) synthesis was then measured using the collagen kit and ELISA,
respectively. Moreover, the enzyme activity, including collagenase, matrixmelloproteinase-2 (MMP-2) and tyrosinase,
were also evaluated.
Results: It was found that the flower extract did not affect skin fibroblast cell growth (IC50 > 200 μg/mL). The results
did show that the flower extract significantly increased collagen and HA synthesis in a dose dependent manner.
The flower extract (50–200 μg/mL) also significantly inhibited collagenase and MMP-2 activity. Furthermore, this
flower extract could inhibit the tyrosinase activity that causes hyperpigmentation, which induces skin aging.
Conclusions: The C. fistula flower extract displayed a preventive effect when used for anti-aging purposes in
human skin fibroblasts and may be an appropriate choice for cosmetic products that aim to provide whitening
effects, and which are designated as anti-aging facial skin care products.
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Background
Skin aging is a complicated biochemical progression
resulting from many individual intrinsic and extrinsic fac-
tors such as age, hormones and exposure to UV light [1].
The progression occurs in the epidermal and dermal
layers and is mainly related to extracellular matrix (ECM)
degradation [2]. The enzymes involved in ECM degrad-
ation are matrix metalloproteinases (MMPs) such as gela-
tinases (MMP-2) and collagenase [3]. Skin loses its tensile
strength due to the effect of ECM degradation by MMPs.
In this process, the wrinkling of skin occurs and
roughness and dryness also markedly arise along with
certain pigment abnormalities such as hypo- or hyper-
pigmentation [2, 4]. For the treatment of hyper-
pigmentation, tyrosinase inhibitors have been investigated.
Tyrosinase is a rate-limiting enzyme that converts tyrosine
to melanin [5]. Tyrosine inhibitors thus play an import-
ance role as skin-lightening agents [6] while hyaluronic
acid (HA) synthesis regulates skin hydration and the
occurrence of wrinkles. HA, a non-sulphated glycosami-
noglycan (GAG), is composed of repeating units of disac-
charides including D-glucuronic acid and N-acetyl-D-
glucosamine [7]. HA also regulates the repair of tissues,
including the enhancement of the immune system re-
sponse by activation of inflammatory cells and in response
to the injury of fibroblasts [8–10].
Natural products made from plant sources such as
Glycyrrhiza glabra [11] or green tea [12] have been used
in cosmetic applications as a source of nutrition and as a
whitening agent. A significant amount of evidence has
pointed to the beneficial effects of orally or topically ad-
ministered phytochemicals from plant extracts, especially
with regard to the improvement of skin conditions. Some
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examples of the beneficial effects are that skin aging and
skin inflammation can be reduced. C. fistula (golden
shower), family Fabaceae, is found in numerous Asian
countries such as Thailand, China, Myanmar and India. In
previous studies, C. fistula flower extract was found to
possess antioxidant, anticancer, antibacterial, antifungal,
and antidiabetic properties [13, 14]. The effect of C. fistula
in Ayurvedic medicine is known to be involved with treat-
ing various disorders including, skin diseases, leprosy,
haematemesis, pruritus and diabetes [15, 16]. Various
parts of C. fistula have displayed pharmacological proper-
ties [17]. The flower, seed, fruit and pulp have been used
to treat skin diseases including leprosy [18]. The pulp has
been recognized for its antidiabetic properties [15] and
has been used in a tonic that has been applied in treat-
ments of gout and rheumatism [19]. The leaves and ripe
pods have been traditionally used as a laxative [20, 21].
The phenolics and flavonoid phytochemicals of C. fistula
have also been reported to be useful in treating skin dis-
eases [14] . Therefore, in this study we are interested in
the roles of C. fistula flower extract in cosmeceutical ap-
plications. The preventive effects of ECM degradation
along with skin aging enzymes that include collagenase
and MMP-2 activities, as well as tyrosinase, have been ex-




Dulbecco’s Modified Eagle Medium (DMEM), DQ gelatin
and penicillin-streptomycin were supplied from Gibco
(Grand Island, NY, USA). Fetal bovine serum (FBS) was sup-
plied from Thermo Scientific (USA). Sirius Red/Fast Green
Collagen Staining Kit was purchased from Chondrex, Inc.
(Redmond, WA, USA). Sulforhodamine B reagent, hyaluro-
nicacid and mushroom tyrosinase were obtained from
Sigma-Aldrich (St. Louis, MO, USA).
Plant materials
C. fistula flowers were obtained from Lampang Herb
Conservation, Lampang Province, Thailand. A voucher
specimen number (023197) was certified by Wannaree
Charoensup, Botanist at the herbarium of the Flora of
Thailand, Faculty of Pharmacy, Chiang Mai University,
Thailand.
Preparation of Cassia fistula flower extract
C. fistula flowers were dried in an airy room and then
500 g of dried flowers were finely ground into powder.
After that, the powder was soaked in 50% ethanol and
then shaken at 70 rpm for 24 h. After 24 h, the samples
were then filtered through filter paper to separate the
residue. The residue was soaked in 50% ethanol and
shaken at 70 rpm for 24 h and this step was repeated 2
times. The filtrated samples were pooled together and
evaporated by a rotary vacuum evaporator (BUCHI,
Switzerland) to obtain the water fractions. Hexane was
added to the water fraction at a ratio of hexane 2:1. The
samples were shaken and allowed to separate over
30 min. The samples were separated into two fractions,
which were hexane and water fractions. Then, the water
fraction was collected and 10% charcoal was added for a
30 min period with mild stirring at room temperature.
The samples were filtered through filter paper and celite
to separate the charcoal. The samples were mixed with
saturated butanol at a ratio of saturated butanol 2:1 and
the samples were allowed to separate over a 12 h period
and this step was repeated 3 times. The samples were
separated into two fractions, which included water and
butanol fractions. Water was further added to the buta-
nol fractions to an equal volume and these fractions
were allowed to evaporate through the use of a rotary
vacuum evaporator. The evaporated samples were
freeze-dried to obtain the C. fistula flower extract
powder.
Quantification of total phenolic content in C. fistula
flower extract using UV-visible spectrophotometer
Total phenolic content in C. fistula flower extract was
determined using the Folin-Ciocalteu assay. Briefly,
0.4 mL of C. fistula flower extract were mixed with
0.3 mL of 10% Folin-Ciocalteau reagent and incubated
in a dark at room temperature for 3 min. Then, 0.3 mL
of sodium carbonate solution was added and the solu-
tion was further incubated in the dark at room
temperature for 30 min. The absorbance was evaluated
at 765 nm using a UV-visible spectrophotometer. The
concentration of the total phenolic content was calcu-
lated and compared with a standard curve for gallic acid
(GA) at 0–20 μg/mL. The total phenolic content was re-
ported as milligrams of GA equivalents per gram of C.
fistula. flower extract (mg GAE/g extract).
Quantification of phenolic compounds in C. fistula flower
extract using HPLC analysis
Various types of phenolic compounds in C. fistula flower
extracts were analyzed using HPLC analysis and were
then compared with standard gallic acid, catechins,
protocatecheuic acid, vanillic acid, chlorogenic acid,
ferulic acid and coumaric acid. The flower extracts were
dissolved in 50% ethanol and were further assessed by
HPLC (Agilent Tecnologies, CA, USA) using reversed-
phase C18 column (WATER, MA, USA). The mobile
phase consisted of methanol (A) and 0.1% trifluoroacetic
acid (TFA) in water (B) with gradient condition. The
flow rate was set at 1.0 mL/min and the detection wave-
length was recorded at 280 with a UV detector. The
concentration levels of the phenolic compounds were
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calculated and compared with the standard curve con-
sidering the standard concentrations and peak areas
(mg/g extract).
Quantification of total flavonoid content in C. fistula
flower extract using colorimetric assay
Total flavonoid content was determined by modified alu-
minium chloride (AlCl3) colorimetric assay as was previ-
ously described [22]. Briefly, 0.25 mL of flower extract
were mixed with 0.125 mL of 5% sodium nitrite
(NaNO2) and the solution was incubated for 5 min at
room temperature. Then, 0.125 mL of 10% AlCl3 were
mixed into the mixture and it was kept in the dark for
5 min. After which, 1 mL of sodium hydroxide (NaOH)
was added and the solution was incubated for 15 min at
room temperature in the dark. The absorbance was mea-
sured at 510 nm using a UV-visible spectrophotometer.
The total flavonoid content was calculated and com-
pared with the standard catechin values and expressed
as mg catechin equivalent per gram of extract (mg CE/g
extract).
Cell cultures
Primary human skin fibroblasts were aseptically isolated
from an abdominal scar after a surgical procedure in-
volving a cesarean delivery at the surgical ward of CM
Maharaj Hospital, Chiang Mai University (Chiang Mai,
Thailand) (Study code: BIO-2558-03549 approved by
Medical Research Ethics Committee, Chiang Mai
University). Fat was removed from the starting material
and it was soaked in DMEM containing anti-penicillin
and streptomycin. After that, the skin was immersed in
DMEM containing 1% protease (Dispase, Gibco, Grand
Island, NY, USA) for 48 h at 4 °C. Epidermal layers were
removed and the normal fibroblasts were isolated from
the dermis. The fibroblasts were cultured in DMEM sup-
plemented with 10% FBS, 2 mM L-glutamine, 50 U/mL
penicillin, and 50 μg/mL streptomycin. The cells were
maintained in a 5% CO2 humidified incubator at 37 °C.
Cell viability assay
The cell viability assay of C. fistula flower extract against
skin fibroblast cells was measured using a sulforhoda-
mine B (SRB) assay as was previously described [23].
Briefly, the cells (8x103cells/well) were seeded in a 96-
well plate and incubated at 37 °C, 5% CO2 for 24 h.
After that, the cells were treated with or without various
concentrations (0–200 μg/mL) of C. fistula flower ex-
tract for 48 h. After 48 h, 10% (w/v) Trichloroacetic acid
(TCA) was added to the cells and the cells were then in-
cubated at 4 °C for 1 h. The medium was removed and
the cells were rinsed with slow running tap water.
0.057% (w/v) SRB solution (100 μL) was added to each
well and the cells were incubated for 30 min at room
temperature. The SRB solution was removed and then
the cells were washed 4 times with 1% (v/v) acetic acid
and they were allowed to dry at room temperature. The
dye was dissolved with 10 mM Tris base solution
(pH 10.5) and the absorbance was measured at 510 nm
using a microplate reader.
Collagen synthesis assay
Total intracellular collagen in the fibroblast cells was de-
termined using Sirius Red/Fast Green Collagen Staining
Kit (Chondrex, Inc, Redmond, WA, USA) according to
the manufacturer’s instructions. Briefly, skin fibroblast
cells were seeded in 24 well plates for 24 h at 37 °C, 5%
CO2. After that, the cells were pre-treated with the
serum free DMEM medium for 24 h. The medium was
removed and the cells were then incubated with or with-
out C. fistula flower extract (0-150 μg/mL) for 48 h.
After 48 h, the cultured medium was removed. Then,
the cells were washed with PBS and fixed with Kahle
fixative for 10 min. The fixative was removed and the
cells were washed with PBS. The Sirius Red/Fast Green
dye solution was added to each well and the specimens
were incubated for 30 min at room temperature. The dye
was removed and the cells were washed four times with
DI water or until the fluid was colorless. Finally, the ex-
traction buffer was added and the absorbance was mea-
sured at 540 nm and 605 nm using a UV-visible
spectrophotometer.
Collagenase activity assay
The collagenase activity was measured using modified
fluorogenic DQ™-gelatin assay as has been previously de-
scribed [24]. Briefly, various concentrations of C. fistula
flower extract (0–200 μg/mL) were added in 96 well
plates. One U/ml of collagenase was added in each well
(100 μL/well). After that, 15 μg/mL of gelatin (DQ gelatin)
was added and the mixtures were incubated for 10 min.
The rate of proteolysis was determined by measuring the
absorbance at 2 min intervals for 20 min using a micro-
plate reader at an excitation wavelength of 485 nm and an
emission wavelength of 528 nm. Enzyme activity was esti-
mated by examining the slope of linear regression between
time and absorbance over a 2-6 min period.
MMP-2 activity assay
The MMP-2 activity was determined by gelatin zymo-
graphy as was previously described [25]. Fibroblast cells
were cultured in DMEM serum-free medium for 24 h.
After that, the culture supernatant was collected. The
culture supernatant was subjected to 10% polyacryl-
amide gels containing 0.1% w/v of gelatin under non-
reducing conditions. The gels were washed twice with
2.5% v/v of Triton X-100 for 30 min at room
temperature to remove SDS. The gel slab was cut into
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slices which corresponded to the lanes and then the
slices were put into different tanks and were incubated
with an activating buffer (50 mM Tris-HCl, 200 mM
NaCl, 10 mM CaCl2, pH 7.4) containing various concen-
trations of C. fistula flower extract (0–200 μg/mL) at
37 °C for 18 h. After that, a strip of the gels was washed
and stained with Coomassie Brillant Blue R (0.1% w/v)
and then was destained in 30% methanol and 10% acetic
acid. MMP-2 activity appeared as a clear band against a
blue background. Digestion bands were quantitated by
the Image J program.
Hyaluronic Acid (HA) synthesis assay by ELISA
The effect of C. fistula flower extract on HA synthesis
was determined using an ELISA kit as previously de-
scribed [26]. The fibroblast cells (5.0 × 104 cells/well)
were seeded in 24-well-plates for 24 h at 37 °C, 5%CO2.
The cells were pre-treated in serum free medium for 6 h
and were then treated with or without various concen-
trations of C. fistula flower extract (0–200 μg/mL) for
48 h. The cultured medium was collected and HA syn-
thesis was measured by ELISA. The absorbance was
measured at 450 and 570 nm using a microplate reader.
The HA concentration in the cultured supernatant ac-
quired from the treated fibroblast cells was calculated
and compared with the standard curve of HA.
Tyrosinase inhibition assay
Tyrosinase inhibition assay was determined as was pre-
viously described [27]. Various concentrations of C. fis-
tula flower extract were added to a 96-well-plate. The
reaction was carried out in a sodium buffer (pH 6.4)
containing 100 U/mL mushroom tyrosinase. L-DOPA
substrate (1 mM) was added into the reaction mixture
and it was then incubated for 10 min at room
temperature. The change of the absorbance at 490 nm
was measured every 1.5 min for 15 min using a micro-
plate reader. The percent inhibition of tyrosinase was
calculated by the following formula:
Tyrosinase inhibition %ð Þ ¼ A−Bð Þ=A½   100;
A = slope of control at 490 nm
B = slope of test at 490 nm
Antioxidant activity assay
The antioxidant activity of the C. fistula flower extract was
determined using 1, 1-diphenyl-2-picrylhydrazyl (DPPH)-
free radical activity, as previously described [28]. Various
concentrations of the flower extract (0–100 μg/mL) were
prepared in methanol. 1 mL of 0.002% of DPPH was added
to 1 mL of the flower extract solution and the mixture was
kept in the dark for 30 min. Absorbance was measured at
517 nm using a spectrophotometer. The % inhibition was
calculated and compared with standard vitamin E
(1–100 μg/mL) using the following formula:
Percent inhibition of DPPH activity
¼ Acontrol at 517 nm−Asample at 517 nm
Acontrol at 517 nm
 100
The antioxidant activity of the C. fistula flower ex-
tracts was confirmed using ABTS assay, as was previ-
ously described [29]. ABTS [2, 2′- azino-bis
(ethylbenzthiazoline-6-sulfonic acid)] radical cation was
prepared by mixing 7 mM ABTS stock solution with
2.45 mM potassium persulfate (K2S2O8) (1/1, v/v). The
mixture was incubated in the dark for 12–16 h until the
reaction was completed. The assay was conducted on
990 μL of ABTS solution and 10 μL of the flower extract
(0–4 μg/mL). After 6 min, the absorbance was recorded
immediately at 734 nm using a spectrophotometer. The
percent inhibition of ABTS activity of the flower extract
was calculated using the following equation:
Percent inhibition of ABTS activity
¼ Acontrol at 734 nm−Asample at 734 nm
Acontrol at 734 nm
 100
Statistical analysis
All data are presented as mean ± standard deviation (S.D.)
values. Statistical analysis was analyzed by Prism version
6.0 software using one-way ANOVA with Dunnett’s test.
Statistical significance was determined at * p < 0.05, ** p <
0.01, ***p < 0.001 or **** p < 0.0001.
Results
Phytochemical characterization of C. fistula flower extract
After the step involving freeze-drying the specimens, the
C. fistula flower extract was weighed and further sub-
jected to phytochemical and biological studies. 18.08 g
of C. fistula flower extract was obtained from 500 g of
raw material and the percent yield of the flower extract
was 3.62. The HPLC fingerprint of the C. fistula flower
extracts was determined by HPLC analysis (Fig. 1).
HPLC profile that showed the peak of the phenolic com-
pounds was labeled in terms of the individual compo-
nents at each retention time. The characterization of the
phenolic compounds of C. fistula flower extract is
shown in Table 1. The total phenolic content in the
flower extract was 275.32 ± 14.21 mg GAE/g extract.
The hydroxybenzoic acid derivatives, including vanillic
acid and protocatechuic acid, were found to be 0.95 ±
0.09 and 2.56 ± 0.42 mg/g extract, respectively, whereas
gallic acid was recorded at 0.60 ± 0.02 mg/g extract. The
hydroxycinnamic acid derivatives, including coumaric
acid, ferulic acid, and chlorogenic acid, were detected at
0.39 ± 0.08, 0.80 ± 0.09, and 0.83 ± 0.03 mg/g extract,
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respectively. The flavonoid content was 27.62 ± 3.56 mg
CE/g extract. Catechin, as a flavonol derivative, was
measured at 1.10 ± 0.00 mg/ g extract.
Effect of C. fistula flower extract on fibroblast cells
cytotoxicity
Cytotoxicity testing of C. fistula flower extract on fibro-
blast cells was measured using SRB assay. Fibroblast
cells were treated with or without various concentrations
of the flower extract (0–200 μg/mL). After a treatment
of 48 h, the flower extract was found to have no effect
on skin fibroblast cell growth (0–200 μg/mL). The IC20
and IC50 of the flower extract was found to be more
than 200 μg/mL, which could also be applied in other
experiments without toxicity (Fig. 2).
Effect of C. fistula flower extract on collagen synthesis in
human skin fibroblast cells
Collagen plays a key role in both skin wound healing
and the skin rejuvenation process. Collagen synthesis
from skin fibroblast cells was achieved using a Sirius
Red/Fast Green Collagen Staining Kit. Collagen synthesis
from fibroblast cells was found to have significantly in-
creased in a dose dependent manner after cells were
treated with various concentrations (100–150 μg/mL) of
the flower extract (Fig. 3).
Effect of C. fistula flower extract on collagenase activity
Collagenases are the enzymes that digest native collagen
in the triple helix region. Therefore, the inhibition of
collagenase activity could protect against collagen break-
down. Collagenase activity was measured using fluoro-
genic DQ™-gelatin assay. Collagenase activity was
dramatically decreased in a dose dependent manner after
treating the fibroblasts with the flower extract. At high
concentrations, the flower extract (200 μg/mL) could
completely inhibit collagenase activity (Fig. 4).
Effect of C. fistula flower extract on MMP-2 activity
MMP-2 is an enzyme that is involved in the breakdown of
the extracellular matrix (ECM) and plays an important
role in influencing normal homeostasis, aging and the
wound-healing of the skin. MMP-2 activity was measured
using gelatin zymography. It was determined that MMP-2
secreted from skin fibroblast cells could digest gelatin in
the gel. However, after the gel was incubated with various
Fig. 1 HPLC fingerprint of C. fistula flower extract. The HPLC fingerprint of the flower extract was evaluated using reversed-phase C18 column
and its mobile phase consisted of methanol and 0.1% trifluoroacetic acid (TFA). The flow rate was set at 1.0 mL/min and the detection wavelength
was 280 and 325 nm
Table 1 The phenolic compound content in C. fistula flower
extracts
Compounds (mg/g extract) C. fistula flower extracts
Total phenolic content 275.32 ± 14.21
Vanillic acid 0.95 ± 0.09
Protocatechuic acid 2.56 ± 0.42
Gallic acid 0.60 ± 0.02
Coumaric acid 0.39 ± 0.08
Ferulic acid 0.80 ± 0.09
Chlorogenic acid 0.83 ± 0.03
Total flavonoid content 27.62 ± 3.56
Catechins 1.10 ± 0.00
Fig. 2 Cytotoxicity of C. fistula flower extract on skin fibroblasts. The
cells were treated with or without various concentrations of the flower
extract (0–200 μg/mL) for 48 h. The cell viability was determined using
SRB assay. All assays have been performed in triplicate and the mean
± standard deviations are shown
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concentrations of the flower extract (50–200 μg/mL), the
level of MMP-2 activity was significantly reduced in a dose
dependent manner (Fig. 5).
Effect of C. fistula flower extract on HA synthesis in
human skin fibroblast cells
HA synthesis from skin fibroblast cells was evaluated
using an ELISA kit. After the cells were treated with
various concentrations of the flower extract for 48 h,
HA synthesis was found to have significantly increased
in a dose dependent manner (50–200 μg/mL). After the
fibroblasts were treated with flower extracts at 200 μg/
mL, HA synthesis was induced at a level that was four-
fold when compared with the non-treated cells (Fig. 6).
Effect of C. fistula flower extract on tyrosinase activity
Tyrosinase is an enzyme that is involved in the rate-
limiting step for the control of melanin production.
Therefore, the inhibition of tyrosinase activity tends to
induce skin whitening due to a reduction of melanin
synthesis. When the tyrosinase enzyme was incubated
with the flower extract, it could inhibit tyrosinase activ-
ity in a dose dependent manner at a concentration of
50–200 μg/mL (Fig. 7).
Fig. 3 The effects of C. fistula flower extract on collagen synthesis
were determined using a collagen kit. Fibroblast cells were
pre-treated in serum free medium for 24 h. and were further
treated with or without various concentrations of flower extract
(0–150 μg/mL) for 48 h. The cells were stained with Sirius Red/Fast Green
dye and the absorbance was determined using a UV-spectrophotometer.
All assays have been performed in triplicate and the mean ± standard
deviations are shown as ****p< 0.0001 versus the non-treated cells
Fig. 4 The effect of C. fistula flower extract on collagenase activity was
determined using fluorogenic DQ™-gelatin assay. Various concentrations
of the flower extract (0–200 μg/mL) were mixed with collagenase. After
that, DQ gelatin substrate was added and incubated for 10 min. The rate
of proteolysis was evaluated using a microplate reader. All assays have
been demonstrated in triplicate and the mean± standard deviations are
shown as ****p< 0.0001 versus the control without the extract
Fig. 5 The effects of C. fistula flower extract on MMP-2 activity were
determined using gelatin zymography. Fibroblast cells were cultured
in DMEM serum-free medium for 24 h and the culture supernatant
was subjected to 10% polyacrylamide gels containing 0.1% w/v of
gelatin under non-reducing conditions. The gels were incubated
with or without various concentrations of red rice extract
(0–200 μg/mL) and were then stained with Coomassie Brillant Blue R.
The digestion bands were quantitated by the Image J program. All
assays have been performed in triplicate and the mean ± standard
deviations are shown as *p < 0.05, ***p < 0.001 and ****p < 0.0001
versus the non-treated culture supernatant
Fig. 6 The effects of C. fistula flower extract on HA synthesis were
determined using an ELISA kit. Fibroblast cells were pre-treated in serum
free medium for 6 h and were further treated with or without various
concentrations of the flower extract (0–200 μg/mL) for 48 h. The cultured
medium was collected for ELISA and the absorbance was measured
at 450 and 570 nm using a microplate reader. All assays have been
performed in triplicate and the mean ± standard deviations are shown as
**p< 0.01, ***p< 0.001 and ****p< 0.0001 versus the non-treated cells
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Anti-oxidant activity of C. fistula flower extract
The free radical scavenging activity of C. fistula flower
extract was then examined by DPPH and ABTS assay. C.
fistula flower extract dose dependently inhibited oxidant
activity. Vitamin e and trolox were used as a positive
control in each experiment. C. fistula flower extract ex-
hibited scavenging activity (DPPH assay) at a value of
65% at 100 μg/mL. At 25 μg/mL of the flower extract,
the radical scavenging activity was found to still be ap-
proximately 33% and the IC50 of the flower extract and
vitamin E were recorded at 70 and 72 μg/mL, respect-
ively. These findings indicate that C. fistula flower extract
is a potent antioxidant and in this capacity is comparable
to vitamin E (Fig. 8a). To confirm the anti-oxidant activity
of the flower extract, the ABTS assay was determined and
showed % inhibition of 47% at 4 μg/mL and IC50 of the
flower extract and the trolox were 4.8 and 3 μg/mL, re-
spectively, which was in accordance with the data ac-
quired from the DPPH assay (Fig. 8b).
Discussion
Extrinsic and/or environmental factors cause skin aging
signs which can include wrinkles and pigment spot for-
mations [30]. In previous studies, UV-radiation that is
known to induce skin aging has been a major topic of
research through the focus of the pathogenesis and mo-
lecular mechanisms. The generation of ROS can stimu-
late skin inflammation leading to the activation of
transcription factors which regulate the degradation of
the skin collagen and the extracellular matrix (ECM)
[30]. These events result in a loss of the skin’s ability to
resist stretching, which ultimately leads to skin aging.
C. fistula flower extract has been traditionally used for
the treatment of skin diseases, abdominal pain and
wound-healing [17]. Our results show that the major
phytochemicals represented in the C. fistula flower ex-
tract were the phenolic compounds and flavonoids. The
main phenolic components in the C. fistula flower ex-
tract were protocatecheuic acid followed by vanillic acid,
chlorogenic acid and ferulic acid. In addition, Bahorun
T, et al have reported that C.fistula flowers contain vari-
ous types of flavonoids including kaempferol, rhein,
fistulin, alkaloids and triterpenes. Among those phyto-
chemical compounds, kamempferol, catechins, ferulic
acid, chlorogenic acid and protocatecheuic acid have
been proven to exhibit antiaging activities. In this study,
the antiaging activity of the C. fistula flower extract was
investigated in order to determine the effects of the ex-
tract on collagen, HA and melanin production. Our re-
sults indicate that high concentrations of C. fistula
flower extract (200 μg/ml) did not have an effect on the
viability of human skin fibroblast cells. Therefore, C.
fistula flower extracts could be safe in applications to
the human skin.
Fig. 7 Tyrosinase inhibition assay was determined in the C. fistula
flower extract. Various concentrations of the flower extract were
mixed with 100 U/mL of mushroom tyrosinase in a sodium buffer
(pH 6.4). L-DOPA substrate (1 mM) was added into the reaction
mixture and it was then incubated for 10 min. The change of the
absorbance was measured at 490 using a microplate reader. All
assays have been demonstrated in triplicate and the mean ± standard
deviations are shown ****p < 0.0001 versus the control without
the extract
Fig. 8 Free radical scavenging activity of C. fistula flower extracts
was determined using DPPH assay (a) and ABTS assay (b). 1 mL of
0.002% of DPPH was added to 1 mL of the flower extract solution
and it was kept in the dark for 30 min. Absorbance was measured at
517 nm using a spectrophotometer. Percent inhibition of the DPPH
radical was calculated and compared with that of standard vitamin E.
For ABTS assay, the flower extract was mixed with ABTS solution and
was then incubated for 6 min. Absorbance was measured at 734 nm
using a spectrophotometer. Percent inhibition of the ABTS radical was
calculated and compared with that of the standard trolox. All assays
have been demonstrated in triplicate and the mean ± standard
deviations are shown as ****p < 0.0001 versus control
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Collagen synthesis in skin fibroblasts plays a major
role in skin rejuvenation. The reduction of types I and
III procollagen synthesis is a critical feature of aged skin
leading to skin thinning and the increased fragility of
skin. [31]. Hence, the inhibition of collagen synthesis or
a loss in the function of collagen results in chronologic-
ally aged skin. Our results indicate that the C. fistula
flower extract significantly induced collagen synthesis
from the skin fibroblasts and also dramatically inhibited
collagenase activity, which is the enzyme involved in col-
lagen breakdown. Chronologically aged skin induced by
UV radiation also occurs through an increase in MMPs
production, including, MMP-1, MMP-2, MMP-3 and
MMP-9, which causes an imbalance of collagen synthesis
by the induction of collagen or by ECM degradation [32].
This is the first report indicating that C. fistula flower ex-
tracts significantly inhibit MMP-2 activity in a dose
dependent manner. For applications in cosmetic formula-
tions, the C. fistula extract at a concentration of 50 μg/mL
should be considered. These findings suggest that C.
fistula flower extract possesses useful booster collagen
benefiting the skin via reduced collagen breakdown.
Glycosaminoglycans (GAGs) or hyaluronic acid (HA),
a major component of extracellular matrix, is induced
during wound-healing and skin regeneration and keeps
skin hydrated [33]. Environmental factors such as UV
radiation induce the type of skin aging that results in a
loss of skin elasticity causing skin to become wrinkled
by decreasing HA synthesis [34]. This result indicates
that the C. fistula flower extract dramatically increased
HA synthesis in a dose dependent manner. Hence, the
flower extract can enhance skin moisture and can result
in skin being less dry by increasing HA synthesis.
Hyperpigmentation causes human skin aging and oc-
curs as a result of both internal and external factors in-
cluding those related to hormones, UV exposure, drugs,
and the presence of various chemicals [4]. Melanin bio-
synthesis is a pathway that appears in melanocytes.
Hyperpigmentation is particularly obvious in darker skin
and is often difficult to treat. Cosmetic scientists have
conducted various in vivo and in vitro studies on skin
lightening agents. The key enzyme that regulates mel-
anin synthesis is tyrosinase, which is involved in two
steps of melanin synthesis, including the hydroxylation
of tyrosine to β-3,4-dihydroxyphenylalanine (DOPA) and
the oxidation of DOPA to DOPA quinone [4]. Our re-
sults indicate that the C. fistula flower extract can suc-
cessfully reduce tyrosinase activity. This result was
similar to that of certain previous studies, which showed
that C. fistula pods have displayed skin whitening activ-
ity in vitro and in vivo by using tyrosinase activity as an
endpoint bioassay [35]. Therefore, it can be concluded
that this C. fistula flower extract can reduce hyperpig-
mentation in human skin. Previous studies have shown
that some parts of the C. fistula plant exhibited anti-
oxidant activity [36–38]. The aqueous and methanolic
extracts of the C. fistula bark showed the free radical
scavenging effect of DPPH in a dose dependent manner
[38]. The hydroalcoholic extract of the C. fistula flower
and fruit pulp showed antioxidant activity by inhibiting
DPPH and hydroxyl radicals [36, 37]. Additionally, our
study on the anti-oxidant activity of the butanolic ex-
tract of the C. fistula flower similarly displayed the free
radical scavenging effect of DPPH and ABTS in a dose
dependent manner.
Conclusions
These results indicate that C. fistula flower extract displays a
high potential for anti-aging in normal skin fibroblast cells,
both in terms of the inhibition of wrinkles and a decrease in
the number of pigment spots. C. fistula flower extract could
prevent skin aging via an increase in collagen and HA
production. Moreover, the flower extract also inhibited col-
lagenase, MMP-2 and tyrosinase activity, all of which are in-
volved in skin aging. Therefore, C. fistula extract that has
displayed a non-toxic effect might be an alternative ingredi-
ent for use in cosmetics or supplements that are being de-
veloped for anti-aging applications.
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